2017
DOI: 10.1136/ejhpharm-2016-001188
|View full text |Cite
|
Sign up to set email alerts
|

Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer

Abstract: ObjectiveTo determine and evaluate the pharmaceutical care needs and quality of life of patients with colorectal cancer.Methods36 Patients with colorectal cancer eligible for chemotherapy after surgery were included in the study. The patients were followed up during 3 courses of chemotherapy and individual pharmaceutical care plans were developed. The quality of life of patients was evaluated before and after the third course of chemotherapy.ResultsThe incidence of drug-related problems (DRPs) in chemotherapy-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
13
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 18 publications
0
13
0
3
Order By: Relevance
“…A drug-related problem (DRP) is an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes [7]. In several studies investigating the role of the pharmacist in the management of NCDs, such as cancer, chronic obstructive pulmonary disease (COPD), asthma, diabetes and hypertension, the rate of DRPs ranged between 20 and 75% [4,[8][9][10][11]. As DRPs may be prevented, detected and resolved in community pharmacy settings, the input of the pharmacist is essential.…”
mentioning
confidence: 99%
“…A drug-related problem (DRP) is an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes [7]. In several studies investigating the role of the pharmacist in the management of NCDs, such as cancer, chronic obstructive pulmonary disease (COPD), asthma, diabetes and hypertension, the rate of DRPs ranged between 20 and 75% [4,[8][9][10][11]. As DRPs may be prevented, detected and resolved in community pharmacy settings, the input of the pharmacist is essential.…”
mentioning
confidence: 99%
“…Evaluation of symptom-related quality of life is important for the monitoring of patients receiving chemotherapy [499].…”
Section: Colorectal Cancermentioning
confidence: 99%
“…Also, the clinical oncology pharmacist has an important role in the identification and resolution of DRPs. Evaluation of symptom-related quality of life is important for the monitoring of patients receiving chemotherapy [499].…”
Section: D) Colorectal Cancermentioning
confidence: 99%